**Pieris Pharmaceuticals Announces Results of 2024 Annual Meeting and Updates on Merger Agreement**On December 2, 2024, Pieris Pharmaceuticals, Inc. (NASDAQ: PIRS) held its annual meeting of stockholders where significant decisions were made. A quoru
This article was generated by an automated content engine and was reviewed by a human editor prior to publication. For additional information, read Pieris Pharmaceuticals’s 8K filing here. About Pieris Pharmaceuticals (Get Free Report) Pieris Pharmaceuticals, Inc, a biotechnology company, discovers and develops biotechnological applications. The company focuses on the development of its 4-1BB bispecifics […]
More Stories
Iran Attacks 2 Container Ships After Trump Extends Ceasefire
By Tom Ozimek Iranian forces fired on two commercial vessels near the Strait of Hormuz on April 22, UK maritime...
Southern Poverty Law Center Charged With Fraud Over Payments to Informants in Extremist Groups
By Tom Gantert The Southern Poverty Law Center was indicted on federal fraud charges that accused it of illegally raising...
Dr. Oz Says Anti-Fraud Effort Coming to ‘All 50 States’
By Jack Phillips Dr. Mehmet Oz, the administrator of the agency overseeing Medicaid and Medicare, announced Tuesday that his agency’s...
US Retail Sales Jump in March as Higher Gas Prices Lift Spending
By Bill Pan Americans kept on spending in March amid a sharp rise in gasoline prices, new government data suggest....
Trump Announces Extension of Iran Ceasefire
By Jack Phillips President Donald Trump on Tuesday announced he is extending a ceasefire with Iran, citing what he said...
Democratic Rep. Cherfilus-McCormick Resigns Ahead of Ethics Committee Sanctions Hearing
By Chase Smith Rep. Sheila Cherfilus-McCormick (D-Fla.) resigned from Congress on Tuesday, stepping down hours before the House Ethics Committee...